Works matching IS 0195668X AND DT 2020 AND VI 41 AND IP 24

Results: 24
    1
    2

    Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel.

    Published in:
    European Heart Journal, 2020, v. 41, n. 24, p. 2313, doi. 10.1093/eurheartj/ehz962
    By:
    • Borén, Jan;
    • Chapman, M John;
    • Krauss, Ronald M;
    • Packard, Chris J;
    • Bentzon, Jacob F;
    • Binder, Christoph J;
    • Daemen, Mat J;
    • Demer, Linda L;
    • Hegele, Robert A;
    • Nicholls, Stephen J;
    • Nordestgaard, Børge G;
    • Watts, Gerald F;
    • Bruckert, Eric;
    • Fazio, Sergio;
    • Ference, Brian A;
    • Graham, Ian;
    • Horton, Jay D;
    • Landmesser, Ulf;
    • Laufs, Ulrich;
    • Masana, Luis
    Publication type:
    Article
    3

    Statin therapy increases lipoprotein(a) levels.

    Published in:
    European Heart Journal, 2020, v. 41, n. 24, p. 2275, doi. 10.1093/eurheartj/ehz310
    By:
    • Tsimikas, Sotirios;
    • Gordts, Philip L S M;
    • Nora, Chelsea;
    • Yeang, Calvin;
    • Witztum, Joseph L
    Publication type:
    Article
    4
    5
    6

    Effect of alirocumab on cardiovascular outcomes after acute coronary syndromes according to age: an ODYSSEY OUTCOMES trial analysis.

    Published in:
    European Heart Journal, 2020, v. 41, n. 24, p. 2248, doi. 10.1093/eurheartj/ehz809
    By:
    • Sinnaeve, Peter R;
    • Schwartz, Gregory G;
    • Wojdyla, Daniel M;
    • Alings, Marco;
    • Bhatt, Deepak L;
    • Bittner, Vera A;
    • Chiang, Chern-En;
    • Flores, Roger M Correa;
    • Diaz, Rafael;
    • Dorobantu, Maria;
    • Goodman, Shaun G;
    • Jukema, J Wouter;
    • Kim, Yong-Un;
    • Pordy, Robert;
    • Roe, Matthew T;
    • Sy, Rody G;
    • Szarek, Michael;
    • White, Harvey D;
    • Zeiher, Andreas M;
    • Steg, Ph Gabriel
    Publication type:
    Article
    7
    8
    9
    10
    11

    Cholesterol crystals and atherosclerosis.

    Published in:
    European Heart Journal, 2020, v. 41, n. 24, p. 2236, doi. 10.1093/eurheartj/ehaa505
    By:
    • Baumer, Yvonne;
    • Mehta, Nehal N;
    • Dey, Amit K;
    • Powell-Wiley, Tiffany M;
    • Boisvert, William A
    Publication type:
    Article
    12
    13
    14

    Staying on the same wavelength.

    Published in:
    European Heart Journal, 2020, v. 41, n. 24, p. 2231, doi. 10.1093/eurheartj/ehaa463
    By:
    • Ozkan, Judy
    Publication type:
    Article
    15
    16
    17
    18
    19

    The Spanish Society of Cardiology.

    Published in:
    European Heart Journal, 2020, v. 41, n. 24, p. 2244, doi. 10.1093/eurheartj/ehaa384
    By:
    • Sánchez-Recalde, Angel
    Publication type:
    Article
    20

    Francesco Paneni.

    Published in:
    European Heart Journal, 2020, v. 41, n. 24, p. 2243, doi. 10.1093/eurheartj/ehaa347
    By:
    • Nicholls, Mark
    Publication type:
    Article
    21
    22
    23

    Potent lipoprotein(a) lowering following apolipoprotein(a) antisense treatment reduces the pro-inflammatory activation of circulating monocytes in patients with elevated lipoprotein(a).

    Published in:
    European Heart Journal, 2020, v. 41, n. 24, p. 2262, doi. 10.1093/eurheartj/ehaa171
    By:
    • Stiekema, Lotte C A;
    • Prange, Koen H M;
    • Hoogeveen, Renate M;
    • Verweij, Simone L;
    • Kroon, Jeffrey;
    • Schnitzler, Johan G;
    • Dzobo, Kim E;
    • Cupido, Arjen J;
    • Tsimikas, Sotirios;
    • Stroes, Erik S G;
    • Winther, Menno P J de;
    • Bahjat, Mahnoush
    Publication type:
    Article
    24